ENDRA Life Sciences Inc. — Director's Dealing 2020

Apr 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-04-09

Reporting Person: Maloberti Renaud Bertrand (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-09	Common Stock	A	86580	$0.00	Acquired	86580	Direct

Footnotes

F1: Represents restricted stock units granted in lieu of a portion of the Reporting Person's cash salary. Subject to continued employment, the restricted stock units vest each day, pro rata based on the number of days between the grant date and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of
the Issuer's common stock.

F2: Includes unvested restricted stock units.